Service de Réanimation Médicale Polyvalente, Centre Hospitalier Public du Cotentin, BP 208, 50102, Cherbourg-Octeville, France.
Service de Réanimation Médicale, Centre Hospitalier Universitaire de Caen, Avenue de la Côte de Nacre, 14033, Caen, France.
Ann Intensive Care. 2016 Dec;6(1):65. doi: 10.1186/s13613-016-0170-4. Epub 2016 Jul 16.
Elevation of the immature/total granulocyte (I/T-G) ratio has been reported after out-of-hospital cardiac arrest (OHCA). Our purpose here was to evaluate the prognostic significance of the I/T-G ratio and to investigate whether the I/T-G ratio improves neurological outcome prediction after OHCA.
This single-center prospective cohort study included consecutive immunocompetent patients admitted to our intensive care unit over a 3-year period (2012-2014) after successfully resuscitated OHCA. The I/T-G ratio was determined in blood samples collected at admission.
We studied 204 patients (77 % male, median age, 58 [48-67] years), of whom 64 % had a suspected cardiac cause of OHCA, 62 % died in the unit, and 31.5 % survived with good cerebral function. Independent outcome predictors by multivariate analysis were age, first shockable rhythm, bystander-initiated resuscitation, and I/T-G ratio. Compared to the model computed without the I/T-G ratio, the model with the ratio performed significantly better [areas under the ROC curves (AUCs), 0.78 vs. 0.83, respectively; P = 0.04]. These items were used to develop the MyeloScore equation: ([0.47 × I/T-G ratio] + [0.023 × age in years]) - 1.26 if initial VF/VT - 1.1 if bystander-initiated CPR. The MyeloScore predicted neurological outcomes with similar accuracy to the previously reported OHCA score (0.83 and 0.85, respectively; P = 0.6). The ROC-AUC was 0.84, providing external validation of the MyeloScore.
The I/T-G ratio independently predicts neurological outcome after OHCA and, when added to other known risk factors, improves neurological outcome prediction. The clinical performance of the MyeloScore requires evaluation in a prospective study.
院外心脏骤停(OHCA)后,不成熟/总粒细胞(I/T-G)比值升高。我们的目的是评估 I/T-G 比值的预后意义,并探讨 I/T-G 比值是否能改善 OHCA 后的神经功能预后预测。
这是一项为期 3 年(2012-2014 年)的单中心前瞻性队列研究,纳入了在免疫功能正常的患者成功复苏后入住我们重症监护病房的连续患者。在入院时采集血样测定 I/T-G 比值。
我们研究了 204 例患者(77%为男性,中位年龄 58[48-67]岁),其中 64%的 OHCA 病因可疑为心脏原因,62%在重症监护病房死亡,31.5%存活且神经功能良好。多变量分析的独立预后预测因素为年龄、首次可除颤节律、旁观者启动心肺复苏和 I/T-G 比值。与未纳入 I/T-G 比值的模型相比,纳入该比值的模型表现更好[ROC 曲线下面积(AUCs)分别为 0.78 和 0.83,P=0.04]。这些项目被用于开发 MyeloScore 方程:[(0.47×I/T-G 比值)+(0.023×年龄)]-1.26(初始为室颤/室速),1.1(旁观者启动 CPR)。MyeloScore 对神经功能预后的预测准确性与之前报道的 OHCA 评分相似(分别为 0.83 和 0.85,P=0.6)。ROC-AUC 为 0.84,为 MyeloScore 提供了外部验证。
I/T-G 比值独立预测 OHCA 后的神经功能预后,当与其他已知危险因素相结合时,可改善神经功能预后预测。MyeloScore 的临床性能需要在前瞻性研究中进行评估。